The Tobacco Control Research Group, from IDIIBELL and ICO, awarded by the World Health Organization (WHO) with one of the World No Tobacco Day 2021 Awards for its work and achievements in the tobacco control field. In fact, each year the WHO recognizes people and/or institutions from each of the six regions of the organization.

Among this year’s winners, in the European Region, we can find the Research Group on Tobacco Control, as well as the Secretary-General of the European Network for Smoking and Tobacco Prevention, Cornel Radu-Loghin; the Ministry of Health of the Russian Federation; the German Network of Tobacco Free Hospitals and Health Services of the Federal Republic of Germany; and Dr. Müserref Pervin Tuba Durga, Vice President for Health, Family, Labor and Social Affairs of the Commission of the Grand National Assembly of the Republic of Turkey.

According to the group leader of the Tobacco Control Research Group, Esteve Fernández, “this award recognizes the work of the Tobacco Control Unit for the last 15 years, with national and international impact. During these years, they have implemented interventions such as the Catalan Network of Smoke-free Hospitals or other specific programs, the research in the consumption and exposure to environmental tobacco smoke, the evaluation of tobacco laws, the training and dissemination in tobacco control”. And he adds, “we hope that this recognition will impact health institutions and authorities to support us in the various activities promoted by the Unit.”

May 31, World No Tobacco Day

World No Tobacco Day, celebrated on May 31, aims to inform society of the dangers posed by tobacco consumption, the commercial practices of tobacco companies, and the activities organized by the WHO to fight against the epidemic of tobacco. This celebration was established in 1987 by the World Health Assembly to make the world population aware of the devastating effects of smoking on health.

The Bellvitge Biomedical Research Institute (IDIBELL) is a biomedical research center created in 2004. It is participated by the Bellvitge University Hospital and the Viladecans Hospital of the Catalan Institute of Health, the Catalan Institute of Oncology, the University of Barcelona and the City Council of L’Hospitalet de Llobregat.

IDIBELL is a member of the Campus of International Excellence of the University of Barcelona HUBc and is part of the CERCA institution of the Generalitat de Catalunya. In 2009 it became one of the first five Spanish research centers accredited as a health research institute by the Carlos III Health Institute. In addition, it is part of the “HR Excellence in Research” program of the European Union and is a member of EATRIS and REGIC. Since 2018, IDIBELL has been an Accredited Center of the AECC Scientific Foundation (FCAECC).

RELATED CONTENT


Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

ORYZON selected as Associated Partner in...

by Oryzon Genomics

Oryzon to validate epigenetic agents by applying a personalized medici...

Photos Stream